MONTIOLI, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 1.997
EU - Europa 1.743
AS - Asia 826
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
AF - Africa 2
Totale 4.584
Nazione #
US - Stati Uniti d'America 1.976
GB - Regno Unito 726
CN - Cina 723
IT - Italia 267
SE - Svezia 171
IE - Irlanda 139
FR - Francia 137
DE - Germania 105
FI - Finlandia 103
UA - Ucraina 39
SG - Singapore 33
BE - Belgio 20
VN - Vietnam 20
CA - Canada 19
KR - Corea 18
JP - Giappone 15
RU - Federazione Russa 11
AU - Australia 5
ES - Italia 4
NL - Olanda 4
AT - Austria 3
CL - Cile 3
EU - Europa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
GR - Grecia 2
HK - Hong Kong 2
IL - Israele 2
IN - India 2
IQ - Iraq 2
PT - Portogallo 2
TR - Turchia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
IR - Iran 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 4.584
Città #
Southend 665
Chandler 384
Jacksonville 255
Ann Arbor 206
Woodbridge 172
Beijing 139
Dublin 139
Verona 127
Houston 119
Jinan 86
Ashburn 82
Shenyang 75
Wilmington 70
Nanjing 63
Lawrence 58
Princeton 58
New York 56
Redmond 43
Hebei 39
Ningbo 33
Tianjin 29
Changsha 28
Helsinki 28
Seattle 24
Nanchang 23
Haikou 22
Zhengzhou 22
Singapore 21
Falls Church 20
Lanzhou 20
Brussels 19
Hangzhou 18
Redwood City 17
Seoul 17
Taiyuan 16
Lancaster 13
Taizhou 13
Dong Ket 12
Jiaxing 12
Kent 12
Tokyo 12
Boardman 11
Guangzhou 11
Milan 11
Sindelfingen 11
Fuzhou 9
Toronto 9
Dearborn 8
Elora 8
Norwalk 7
Birmingham 6
Parma 6
Rome 6
San Francisco 6
Kemerovo 5
Los Angeles 5
Perugia 5
Auburn Hills 4
Cagliari 4
Fairfield 4
Chicago 3
Detroit 3
Dongguan 3
London 3
Madrid 3
Padova 3
Pieve di Soligo 3
Qingdao 3
Sydney 3
Washington 3
Xiangfen 3
Boston 2
Cambridge 2
Chions 2
Clearwater 2
Cormano 2
Dubai 2
Glasgow 2
Kirrweiler 2
Lappeenranta 2
Las Vegas 2
Mainz 2
Martignacco 2
Montreal 2
Nashville 2
Nürnberg 2
Orzinuovi 2
Piacenza 2
Rubano 2
San Diego 2
Sofia 2
Tappahannock 2
Torviscosa 2
Vienna 2
Amsterdam 1
Aprilia 1
Augusta 1
Aversa 1
Azzano Decimo 1
Baku 1
Totale 3.488
Nome #
Analisi cinetiche, spettrofotometriche e mutazionali di due enzimi PLP-dipendenti del fold type I. Meccanismi catalitici, processi di folding e dimerizzazione 208
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 136
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 134
Holo-and apocystalysin from Treponema denticola: two different conformations 130
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 123
The novel R347g pathogenic mutation Of aromatic amino acid decarboxylase provides additional molecular insights into enzyme catalysis and deficiency 112
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 104
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 100
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 99
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 98
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 96
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 93
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 90
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 89
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 88
The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase 86
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 86
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 86
Radiation damage at the active site of human alanine:glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis 85
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 84
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 83
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 83
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 82
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 82
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 82
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 81
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 80
Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T 80
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 77
Pathogenic variants of human Aromatic L-Amino Acid Decarboxylase: evidences of misfolding in functionally active variants 77
Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase 76
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 75
Extensive deamidation of RNase A inhibits its oligomerization through 3D domain swapping 75
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 75
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 74
New variants of AADC deficiency expand the knowledge of enzymatic phenotypes 73
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 69
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 67
Oligomeric state and thermal stability of apo- and holo- human ornithine δ-aminotransferase 66
Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5'-Phosphate Histidine Decarboxylase 66
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 65
Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations 64
Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis 63
Properties of RNase A monomer and dimers depend on the oligomerization pathway followed. 63
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook 61
Aromatic amino acid decarboxylase deficiency: the added value of biochemistry 61
Molecular insights into primary hyperoxaluria Type I pathogenesis. 60
Parkinson's Disease: recent updates in the identification of human dopa decarboxylase inhibitors 60
RNase A domain-swapped dimers produced through different methods: structure–catalytic properties and antitumor activity 60
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 57
Deciphering the fate of slan+ -monocytes in human tonsils by gene expression profiling 57
Compound heterozygosis in AADC deficiency: A complex phenotype dissected through comparison among heterodimeric and homodimeric AADC proteins 55
Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects 54
Molecular and cellular studies reveal folding defects of human ornithine aminotransferase variants associated with gyrate atrophy of the choroid and retina 51
R180T variant of δ-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-RAY and NMR studies provide insight into its catalytic features 49
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 43
Dimerization of human angiogenin and of variants involved in neurodegenerative diseases 39
A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies 34
Biochemical and bioinformatic studies of mutations of residues at the monomer-monomer interface of human ornithine aminotransferase leading to gyrate atrophy of choroid and retina 12
Human RNase 1 can extensively oligomerize through 3D domain swapping thanks to the crucial contribution of its C-terminus 9
Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations 8
Totale 4.675
Categoria #
all - tutte 14.204
article - articoli 13.020
book - libri 0
conference - conferenze 601
curatela - curatele 0
other - altro 369
patent - brevetti 0
selected - selezionate 0
volume - volumi 214
Totale 28.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 0 0 20
2019/2020611 62 10 8 40 50 63 69 26 26 66 48 143
2020/2021618 129 90 27 77 79 50 9 37 24 19 52 25
2021/2022716 51 242 116 29 25 11 10 36 22 21 34 119
2022/20231.071 76 131 87 191 93 243 20 53 122 6 29 20
2023/2024478 21 40 37 60 40 92 16 45 3 23 89 12
Totale 4.675